Arch Therapeutics Inc (ARTH)

[Regis999]

I see that you are posting the same posts on Yahoo also and receiving respones there also. Let me take a shot at a few.

Let's see. So they have enough cash to get through CE Mark in Europe. So they will joint venture with someone like JNJ who has 60% of the market now. JNJ does the distribution in Europe and Arch gets enough capital to do US testing.

Per Form 10-Q it will take $ 10- $ 14 million to get full Europe and US approvals. Small in biotech world. Outstanding warrants have raised many millions recently through exercise. More to come.

They have raised $ 12,990,669 since going public.

A lot of your questions are answered here:

http://www.archtherapeutics.blogspot.com/

A CLEAR LIQUID noncoagulant homostatic agent classified as a MEDICAL DEVICE.